September 9, 2022 – BD announced Puneet Sarin has been named president of BD Medication Management Solutions, and Steve Conly has been named president of BD Biosciences, both effective Oct. 3.
In these roles, Sarin and Conly will be responsible for driving global strategic, operational and commercial performance of their respective business units. Sarin will report to Mike Garrison, executive vice president (EVP) and president of the Medical segment, and Conly will report to Dave Hickey, EVP and president of the Life Sciences segment.
Puneet Sarin, president of Medication Management Solutions
Sarin, 48, replaces Mike Garrison who was recently promoted to EVP and president of the BD Medical segment. Sarin joined BD in 2019 as president of BDB and has reinvigorated innovation and simplified the customer experience. Earlier this year, BDB unveiled a first-to-world cell sorter that combines advanced spectral flow cytometry with sort-capable image analysis, which has solidified BD’s technology leadership in flow cytometry. He also simplified the customer experience through a reimagined digital marketplace designed to provide an enhanced online purchasing experience for users and their procurement teams. Prior to BD, Sarin held a variety of P&L leadership roles at Danaher and GE Healthcare. Puneet earned his Bachelor of Science in Mechanical Engineering from Milwaukee School of Engineering and his Master of Business Administration from Emory University.
Steve Conly, president of Biosciences
Conly, 39, replaces Sarin who has been named president of MMS. Conly joined BD in 2010 as a marketing manager for Laboratory Automation in the Integrated Diagnostic Solutions business. He was promoted to platform leader for Laboratory Automation in 2012 and was then appointed to the platform leadership position for Microbiology in 2015. Conly was promoted to VP and GM for Microbiology in 2016. Conly moved to the Biosciences business unit in 2020 as VP and GM for Research Solutions. He added Clinical Solutions to his responsibilities in 2021. Conly earned his Bachelor of Arts and Science in Biomedical Sciences and Economics from McGill University in Canada.